‘Prioritise IP rights, to create a constant cycle of innovation that will help sustain India’s economy’

PhRMA and its member companies are eager to work with the new government to strengthen the biopharma industry’s relationship with India in order to increase access to medications for Indian citizens.

The Modi Government represents an excellent opportunity for American industries to strengthen and rekindle their relationships with India. We look forward to collaborating with India on ways to improve our partnerships in one of the world’s most dynamic and fastest-growing markets.

Modi understands the crucial role innovation plays in economic development. By prioritising IP rights, a constant cycle of innovation in India could be created that will help sustain India’s economy for years to come.

The Indian people stand to benefit from the new economy envisioned by Modi, as they will ultimately be the beneficiaries of better access to safe, innovative treatments.

(Excerpts from the blog post: http://www.phrma.org/catalyst/new-prime-minister-could-usher-in-a-new-era-for-india)

– John J Castellani, President and Chief Executive Officer, PhRMA